Back to funds

5AM Venture Management, LLC

Updated 6 days ago

Managed by 5Am Venture Management, Llc • Latest filing Q3 2026

Portfolio value
$297M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$318.1M
Q1 2026$360.2M
Q2 2026$287.9M
Q3 2026$297M

Top holdings

16 positions as of Q3 2026

View filing
L

LATIGO BIOTHERAPEUTICS INC

Value
$122.3M
Shares
7.33M
% Port
41.19%
T

ENTRADA THERAPEUTICS INC

Value
$24M
Shares
3.78M
% Port
8.09%
T

TYRA BIOSCIENCES INC

Value
$22.5M
Shares
1.03M
% Port
7.58%
C

CAMP4 THERAPEUTICS CORP

Value
$21.3M
Shares
5.28M
% Port
7.18%
A

ARTIVA BIOTHERAPEUTICS INC

Value
$16.8M
Shares
2.35M
% Port
5.64%
P

PHARVARIS N V

Value
$15.2M
Shares
479.9K
% Port
5.13%
T

TECTONIC THERAPEUTIC INC

Value
$14.1M
Shares
606.7K
% Port
4.76%
C

CELLDEX THERAPEUTICS INC NEW

Value
$13.7M
Shares
422.3K
% Port
4.61%
?
9.N/A

ZENTALIS PHARMACEUTICALS INC

Value
$10.9M
Shares
3.95M
% Port
3.68%
B

BIOHAVEN LTD

Value
$9.9M
Shares
739.0K
% Port
3.32%
M

MAPLIGHT THERAPEUTICS INC

Value
$7.6M
Shares
741.9K
% Port
2.55%
S

SILENCE THERAPEUTICS PLC

Value
$5.2M
Shares
476.2K
% Port
1.75%
A

ALX ONCOLOGY HLDGS INC

Value
$4.2M
Shares
3.06M
% Port
1.43%
T

PROTARA THERAPEUTICS INC

Value
$4.2M
Shares
1.37M
% Port
1.41%
?
15.N/A

EYEPOINT INC

Value
$3.4M
Shares
1.05M
% Port
1.16%
S

SKYE BIOSCIENCE INC

Value
$1.6M
Shares
981.3K
% Port
0.53%

Explore